agent

Front Line Therapy in Non-Small Cell Lung Cancer+

17th March 2008
Nick Thatcher
nicholas thatcher 2 Front Line Therapy in Non Small Cell Lung Cancer
Nick Thatcher

NICK THATCHER, Christie Hospital, Manchester
There is a proven benefit in survival if you give your patients cis-platinum based chemotherapy after resection for non-small cell lung cancer. Nick Thatcher emphasized this fact at the beginning of his

…

Read More+

Audio Journal of Oncology in Advance – March 15th, 2008+

16th March 2008
David Maloney

Volume 16 Number 6 (March 15th, 2008) reporting from:
4th European Congress on Hematologic Malignancies (February 22-24, 2008, Paris)
American Society of Hematology Annual Meeting (December 8-11, 2007 Atlanta)
Chemotherapy Foundation Symposium, November 7-10, 2007, New York

david maloney Audio Journal of Oncology in Advance March 15th, 2008
David Maloney

Nonmyeloablative

…

Read More+

Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma+

26th February 2008
Martin Dreyling
martin dreyling Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma
Martin Dreyling

Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
MARTIN DREYLING, University Hospital Grosshaden, Munich
Since the 1970s therapies for mantle cell lymphoma have greatly extended life, Martin Dreyling told conference delegates in Paris. He

…

Read More+

Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes+

10th December 2007
Pierre Fenaux
pierre fenaux Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes
Pierre Fenaux

PIERRE FENAUX, Paris 13 University
Results from a phase III study presented at ASH suggest that the hypomethylating agent azacitidine should be the new standard of care for patients with high-risk MDS. Pierre Fenaux of Paris 13 University

…

Read More+

New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura+

9th December 2007
Terry Gernsheimer
terry gernsheimer New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura
Terry Gernsheimer

TERRY GERNSHEIMER, University of Washington Medical Center, Seattle
An investigational drug AMG 531 has increased and sustained platelet counts in splenectomized patients with chronic immune thrombocytopenic purpura or ITP. This was in a placebo controlled phase III trial

…

Read More+

Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results+

6th November 2007
ake hjalmarson Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results
Ake Hjalmarson
gordon tomaselli Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results
Gordon Tomaselli

REFERENCE: Late Breaking Clinical Trials, Session 2, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
N Engl J Med 2007;357
AKE HJALMARSON, Sahlgrenska University, Göteborg
COMMENT: GORDON TOMASELLI, Johns Hopkins University, Baltimore
The lipid

…

Read More+

TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?+

5th November 2007
gordon tomaselli TRITON TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?
Gordon Tomaselli
daniel jones TRITON TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?
Daniel Jones

REFERENCE: Late Breaking Clinical Trials 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
GORDON TOMASELLI, Johns Hopkins University, Baltimore
COMMENT: DANIEL JONES, President, American Heart Association, University of Mississippi, Jackson
A potential new

…

Read More+

Endothelin Antagonist Keeps Patients with Hormone Refractory Prostate Cancer Alive Longer+

2nd November 2007
Nicholas James
nicholas james Endothelin Antagonist Keeps Patients with Hormone Refractory Prostate Cancer Alive Longer
Nicholas James
gordon mcvie Endothelin Antagonist Keeps Patients with Hormone Refractory Prostate Cancer Alive Longer
Gordon McVie

REFERENCE: Abstract: 3LB (Presidential Session), ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
NICHOLAS JAMES, Birmingham University
COMMENT: GORDON MCVIE, European Institute of Oncology, Milan
A new drug has improved overall survival

…

Read More+

DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates+

21st September 2007
pedro cahn DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates
Pedro Cahn

REFERENCE: Abstract H-717, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
PEDRO CAHN, Juan A. Fernández Hospital, Buenos Aires
Etravirine provides a chance to rescue patients who are failing non-nucleoside regimens according to 24-week

…

Read More+

Hospital Hand Hygiene Program Successfully Rolled Out+

21st September 2007
lindsay grayson Hospital Hand Hygiene Program Successfully Rolled Out
Lindsay Grayson

REFERENCE: Abstract K-1374, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
LINDSAY GRAYSON, Austin Hospital, Victoria, Australia
A hand hygiene campaign implemented in six hospitals in Victoria, Australia has saved lives from MRSA, and

…

Read More+

BORIS: A. baumanni Highly Resistant β-Lactamase and Varying Susceptibility Patterns+

21st September 2007
Jennifer Lavrrar, Jane Hata, Jeanette Block
jane hata team BORIS: A. baumanni Highly Resistant β Lactamase and Varying Susceptibility Patterns
Jennifer Lavrrar, Jane Hata, Jeanette Block

REFERENCE: Slide Session C2-1360, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
JANE HATA, bioMéríeux Inc, Durham
Reports from the BORIS study call for ongoing surveillance of multi-drug resistant Acinetobacter

…

Read More+

Vancomycin: New Guidelines May Induce Kidney Damage+

19th September 2007
Megan Nguyen
megan nguyen Vancomycin: New Guidelines May Induce Kidney Damage
Megan Nguyen

REFERENCE: Poster Session 104 K-1096, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
MEGAN NGUYEN, Western University in Pomona, California
New vancomycin guidelines that recommend using higher doses may cause kidney damage according to

…

Read More+